Turning white fat into calorie-burning beige fat to help blood sugar in obesity and type 2 diabetes
CRISPR-enhanced adipocyte browning to improve glucose tolerance in obesity and diabetes
Scientists are using CRISPR to make human fat cells act like calorie-burning beige fat to help people with obesity and type 2 diabetes improve blood sugar control.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project ID | NIH-11295541 on NIH RePORTER |
What this research studies
Researchers take human fat progenitor cells and use a CRISPR method to permanently switch on a beige, thermogenic state in those cells, then study how these cells change metabolism when implanted into obese, diabetic mice. The team delivers purified Cas9 protein and guide RNA complexes (not viral vectors) to achieve very high gene knockout efficiency in the lab-grown human cells. By tracking glucose tolerance, insulin sensitivity, body weight, and liver fat in treated mice, they aim to uncover the biological signals by which beige adipose improves whole-body metabolism. This work is intended to build a preclinical foundation for possible future cell-based therapies for metabolic disease.
Who could benefit from this research
Good fit: Ideal candidates would be adults with obesity and type 2 diabetes who are interested in future cell-based therapies or in donating adipose tissue for related research.
Not a fit: People with type 1 diabetes, primary genetic fat disorders, or those unwilling to consider tissue donation or experimental cell therapies are less likely to benefit from this approach.
Why it matters
Potential benefit: If successful, this could lead to new cell-based treatments that improve blood sugar control, reduce body weight, and lower liver fat in people with obesity and type 2 diabetes.
How similar studies have performed: Prior preclinical work from the team and others has shown that implanted beige adipocytes can improve glucose tolerance, insulin sensitivity, reduce weight, and decrease liver steatosis in mouse models, but human clinical testing has not yet occurred.
Where this research is happening
Worcester, United States
- Univ of Massachusetts Med Sch Worcester — Worcester, United States (Active)
Researchers
- Principal investigator: Czech, Michael P — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Czech, Michael P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.